Multiple‐Dose Phase I Trials—Normal Volunteers or Patients? One Viewpoint

Publisher Website
Google Scholar
Abstract
Traditionally, Phase I tolerance trials have been done with normal volunteers to establish single‐ and multiple‐dose tolerance. We feel that the justification for doing multiple‐dose tolerance studies in normals is open to question and that, in fact, more pertinent data can be generated by using the appropriate patient populations for these studies.